← All categories

Biotechnology

Funding activity from Biotechnology companies, ordered by the most recently announced round.

Tracked funding

$3.0B

Funding rounds

80

Companies

67

Latest funding 67

Companies with funding tied to this category.

Multiply LabsSan Francisco, United States

Series B$75.0MOct 6

WhiteLab GenomicsParis, France, France

Series B$26.0MOct 6

Consano BioBurlington, United States

Funding$15.0MOct 5

SereNeuro TherapeuticsBaltimore, United States

Pre-Seed—Oct 5

Varda Space IndustriesEl Segundo, United States

Series D$251.0MSep 30

AnaCardioStockholm, Sweden

Series B$72.5MSep 30

Breye TherapeuticsHørsholm, Denmark

Series A$78.3MSep 29

Aptadir TherapeuticsMilan, Italy

Seed$45.0MSep 29

Serán BioscienceBend, United States

Growth Investment—Sep 29

Life Lab ResourcesSingapore, Singapore

Pre-Series A$1.0MSep 24

EnvedaBoulder, United States

Series E$311.0MSep 23

Kinoxis TherapeuticsMelbourne, Australia

Funding$4.4MSep 22

Novadip BiosciencesMont-Saint-Guibert, Belgium

Convertible Financing$12.0MSep 21

MicroLubLeeds, United Kingdom

Growth Funding$10.1MSep 17

MithrlSan Francisco, United States

Series A$20.0MSep 15

Magnitude BiosciencesSedgefield, United Kingdom

Funding$1.7MSep 15

Ferm LabsZug, Switzerland

Seed$3.5MSep 14

N&E InnovationsSingapore, Singapore

Series A$1.6MSep 10

TensiveMilan, Italy

Convertible Loan$23.2MSep 3

GonGlobalMelbourne, Australia

Funding$780KSep 2

iPremomValencia, Spain

Seed$17.4MSep 2

PANDA TherapeuticsSwitzerland

Grant$186KAug 31

Adaptyv BioLausanne, Switzerland

Series A$39.8MAug 27

Readily DiagnosticsSweden

Grant$941KAug 27

BioactivxSingapore, Singapore

Funding$3.0MAug 26

MAASHBrussels, Belgium

Funding Package$14.1MAug 25

Pixelgen TechnologiesStockholm, Sweden

Series B$15.5MAug 20

MillowGothenburg, Sweden

Funding$2.3MAug 18

ComputomicsTübingen, Germany

Series B$7.3MAug 18

K2 TherapeuticsSingapore, Singapore

Funding$50.0MAug 13

InduProSeattle, United States

Series B$77.0MAug 13

InfinimmuneAlameda, United States

Series A$75.0MAug 12

ExobiosphereEsch-sur-Alzette, Luxembourg

Funding$1.2MAug 11

AquaNab SolutionsHamburg, Germany

Funding—Aug 11

MironidLocation unavailable

Series B$46.0MAug 7

Arboreal BioinnovationsLucknow, India

Series A$27.5MJul 30

XeltisEindhoven, Netherlands

Funding$22.2MJul 28

Moa TechnologyOxford, United Kingdom

Series C$30.0MJul 23

PlantopiaIsrael

Funding$9.0MJul 22

Sightera BiosciencesAntwerp, Belgium

Pre-Seed$3.5MJul 17

En Carta DiagnosticsParis, France

Funding$5.8MJul 10

Alchemab TherapeuticsLondon, United Kingdom

Series A Extension$34.0MJul 9

Respiro DiagnosticsUnited Kingdom

Pre-Seed$1.3MJul 8

ALP BioSwitzerland

Telum TherapeuticsPamplona, Spain

Series A$19.5MJul 1

Rainbow CropsGhent, Belgium

Seed$11.3MJun 16

ONWARD MedicalEindhoven, Netherlands

Growth$40.6MApr 17

BioLaminaSundbyberg, Sweden

Debt Financing$20.0MApr 17

Standing OvationParis, France

Series B$32.4MMar 31

Gilgamesh PharmaUnited States

Series A$60.0MMar 24

Crossbow TherapeuticsUnited States

Series B$77.0MMar 18

R1 TherapeuticsToa Baja, United States

Series A$77.5MMar 17

Prolium BioscienceUnited States

Series A$50.0MMar 3

BreezeBioSouth San Francisco, United States

Series B$60.0MFeb 25

Slate MedicinesRaleigh, United States

Series A$130.0MFeb 24

QT SenseGroningen, Netherlands

Octarine BioCopenhagen, Denmark

Series A$15.0MJan 23

Nordic Bioproducts GroupTurku, Finland

Strategic—Jan 21

ExcivaLondon, United Kingdom

Series B$59.0MJan 20

Converge BioBoston, United States

Series A$25.0MJan 15

Caldera TherapeuticsCambridge, United States

Series A$37.5MJan 14

SynthBio LabsSingapore, Singapore

Series A$35.0MJan 10

Diagonal TherapeuticsCambridge, United States

Series B$125.0MJan 8

EpiBiologicsSan Francisco, United States

Series B$107.0MJan 8

BoltzCambridge, United States

Seed$28.0MJan 7

BlueNaluSan Diego, United States

Angel$11.0MJan 2

SolugenHouston, TX, United States

Series C$60.0MFeb 1